Data supplements
CFPlus Additional Information
This data supplement contains the evidence review document, a patient handout, the full disclosure of competing interests and an easy-to-print algorithm.
Files in this Data Supplement:
In this issue
Jump to section
Related Articles
Cited By...
- Response
- Prevalence and management of dyslipidemia in primary care practices in Canada
- PEER simplified lipid guideline 2023 update: Prevention and management of cardiovascular disease in primary care
- Lignes directrices simplifiees de PEER sur les lipides : actualisation 2023: Prevention et prise en charge des maladies cardiovasculaires en soins primaires
- Canadian dyslipidemia guidelines for family doctors
- Influenza vaccination for the prevention of cardiovascular events
- Risque de symptomes musculaires avec la prise de statines
- Risk of muscle symptoms while taking statins
- Guideline evolution in family medicine
- Cardiovascular risk factor documentation and management in primary care electronic medical records among people with schizophrenia in Ontario, Canada: retrospective cohort study
- Managing type 2 diabetes in primary care during COVID-19
- Prise en charge du diabete de type 2 en soins primaires durant la pandemie de la COVID-19
- The rise of CFPs impact factor
- La hausse du facteur dimpact du MFC
- Rethinking screening during and after COVID-19: Should things ever be the same again?
- Update to the Preventive Care Checklist Form(C)
- Reforming disease definitions: a new primary care led, people-centred approach
- Acetylsalicylic acid for primary prevention of cardiovascular events
- Prise en charge du trouble de consommation dopioides en premiere ligne: Lignes directrices simplifiees de PEER
- Managing opioid use disorder in primary care: PEER simplified guideline
- Lignes directrices de pratique clinique 2018 de Diabete Canada: Principaux messages a lintention des medecins de famille qui traitent les patients atteints de diabete de type 2
- Diabetes Canada 2018 clinical practice guidelines: Key messages for family physicians caring for patients living with type 2 diabetes
- Nonfasting lipid testing: the new standard for cardiovascular risk assessment
- Do PCSK9 inhibitors reduce cardiovascular events?
- The hidden curriculum and continuing professional development for family physicians
- Lignes directrices simplifiees en matiere de prescription de cannabinoides medicaux en soins de premiere ligne
- Simplified guideline for prescribing medical cannabinoids in primary care
- Statin-prescribing trends for primary and secondary prevention of cardiovascular disease
- Complete blood count for screening?
- Cost effectiveness of case-finding strategies for primary prevention of cardiovascular disease: a modelling study
- Lhumour en cote a cote avec les meilleures donnees probantes: Les medecins de famille changent didee a propos des outils, du savoir, de la pratique et de la medecine
- Should primary care guidelines be written by family physicians?: YES
- Laughing alongside the best of evidence: Family physicians change ideas about tools, knowledge, practice, and medicine
- Refutation : Les lignes directrices en soins primaires devraient-elles etre redigees par des medecins de famille?: OUI
- For family physicians, by family physicians?
- Les lignes directrices en soins primaires devraient-elles etre redigees par des medecins de famille?: OUI
- Rebuttal: Should primary care guidelines be written by family physicians?: YES
- Etude SPRINT : Donnees probantes sur les cibles precises de la tension arterielle
- SPRINT to evidence for specific blood pressure targets
- Ecology of family physicians research engagement
- Lecologie de lengagement des medecins de famille dans la recherche
- Is family medicine ready to look where it is heading?
- Simplified lipid guidelines: Prevention and management of cardiovascular disease in primary care